One-Year Follow-Up of The Stent Restenosis (STRESS I) Study 11This study was supported in part by Johnson & Johnson Interventional Systems (Cordis), Incorporated, Warren, New Jersey.-Reference-Cited by-同舟云学术

One-Year Follow-Up of The Stent Restenosis (STRESS I) Study 11This study was supported in part by Johnson & Johnson Interventional Systems (Cordis), Incorporated, Warren, New Jersey.

Published:1998-04 Issue:7 Volume:81 Page:860-865
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

George Charles J,Baim Donald S,Brinker Jeffrey A,Fischman David L,Goldberg Sheldon,Holubkov Richard,Kennard Elizabeth D,Veltri Lisa,Detre Katherine M

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease;Fischman;N Engl J Med,1994

2. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease;Serruys;N Engl J Med,1994

3. Continued benefit of coronary stenting versus balloon angioplasty;Macaya;J Am Coll Cardiol,1996

4. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery;Versaci;N Engl J Med,1997

5. Heparin coated Palmatz-Schatz stents in human coronary arteries;Serruys;Circulation,1996

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome after ablation of atypical atrial flutter: Is induction a feasible approach?;IJC Heart & Vasculature;2024-10

2. Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry;REC: interventional cardiology (English Edition);2024-07-19

3. Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?;Journal of Personalized Medicine;2023-04-28

4. Drug loaded implantable devices to treat cardiovascular disease;Expert Opinion on Drug Delivery;2023-03-28

5. Percutaneous Myocardial Revascularization;Ischemic Heart Disease;2023